treatment-resistant-depression
Articles tagged with “treatment-resistant-depression”
Low-Dose Ketamine Case Studies: Clinical Outcomes and Lessons
What do published low-dose ketamine case studies show? Review of clinical outcomes, dosing patterns, and lessons across depression, pain, and anxiety cases.
Ketamine for Depression
Frequently asked questions about using low-dose ketamine to treat depression, including how it works, response rates, speed of onset, and maintenance strategies.
Ketamine for Depression: A Comprehensive Evidence-Based Guide
An in-depth clinical guide examining the evidence for low-dose ketamine in the treatment of major depressive disorder and treatment-resistant depression. Covers mechanisms of action, clinical trial data, response predictors, duration of effect, maintenance strategies, and cost-benefit analysis.
Ketamine vs TMS (Transcranial Magnetic Stimulation): Two Approaches to Treatment-Resistant Depression
Ketamine vs TMS for treatment-resistant depression: mechanisms, success rates, protocols, side effects, FDA status, and cost compared side by side.
IV Racemic Ketamine vs Esketamine (Spravato): A Clinical Comparison
Evidence-based comparison of IV racemic ketamine and intranasal esketamine (Spravato) for treatment-resistant depression, examining mechanism differences, efficacy data, FDA status, cost, access, and side effects.
IV vs Oral Ketamine: Routes of Administration Compared
Clinical comparison of intravenous and oral ketamine for depression and pain, examining bioavailability, efficacy evidence, convenience, cost, monitoring requirements, and appropriate clinical settings.
Ketamine vs Traditional Antidepressants: Mechanism, Efficacy, and Clinical Role
Ketamine vs SSRIs, SNRIs, and TCAs: how mechanisms, onset, efficacy in treatment-resistant depression, side effects, and access compare in current evidence.
Low-Dose Ketamine for Treatment-Resistant Depression
An evidence-based overview of low-dose ketamine as a rapidly acting antidepressant for patients with treatment-resistant depression, including mechanisms of action, clinical protocols, and outcome data.
Contact Low Dose Ketamine
Send corrections, provider questions, or advertising inquiries.